Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-10-23
1999-12-14
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514323, A61K 3155, A61K 31445
Patent
active
060018283
ABSTRACT:
A pharmaceutical composition comprising: (a) a tumor necrosis factor inhibitor; (b) a compound selected from the group consisting of reverse transcriptase inhibitors, protease inhibitor, a gene inhibitor, myristoylation inhibitors, cell-virus binding inhibitors, LTR promoter site inhibitors, ribosome inactivators, platelet aggregation inhibitors and prophylactic and therapeutic HIV vaccines, and (c) a pharmaceutical inert nontoxic carrier are described.
REFERENCES:
patent: 5641773 (1997-06-01), Pardee et al.
Makonkawkeyoon et al., Proc. Natl. Acad. Sci. USA (1993), 90(13), 5974-8 (Abstract Only).
Andrulis, Jr. Peter
Angres Isaac A.
Angres Isaac
Goldberg Jerome D.
LandOfFree
Use of tumor factor inhibitors together with antiviral agents an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tumor factor inhibitors together with antiviral agents an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tumor factor inhibitors together with antiviral agents an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863573